Display Settings:

Format

Send to:

Choose Destination
Endocr Relat Cancer. 2006 Jun;13(2):293-325.

p53 and breast cancer, an update.

Author information

  • 1Laboratoire Jean-Claude Heuson de Canc√©rologie Mammaire, Institut Jules Bordet - Universit√© Libre de Bruxelles, 127 boulevard de Waterloo, B-1000 Bruxelles, Belgium. Marc.Lacroix@ulb.ac.be

Abstract

p53 plays a key role in mediating cell response to various stresses, mainly by inducing or repressing a number of genes involved in cell cycle arrest, senescence, apoptosis, DNA repair, and angiogenesis. According to this important function, p53 activity is controlled in a very complex manner, including several auto-regulatory loops, through the intervention of dozens of modulator proteins (the 'p53 interactome'). p53 mutations are observed in a significant minority of breast tumours. In the remaining cases, alterations of interactome components or target genes could contribute, to some extent, to reduce the ability of p53 to efficiently manage stress events. While the prognostic and predictive value of p53 is still debated, there is an increasing interest for p53-based therapies. The present paper aims to provide updated information on p53 regulation and function, with specific interest on its role in breast cancer.

PMID:
16728565
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk